TAK-360

N/A

Report date: 2026/05/08 10:00:29
NME

Base Information

Drug NameTAK-360
Drug Alias NameTAK-360
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOrexin receptor type 2 agonists
TargetsOrexin receptor type 2
Therapy Area/IndicationsSleepinessNarcolepsyIdiopathic Hypersomnia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesItalyFrance +[8] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesTakeda Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTakeda (China) International Trading Co LtdTakeda Pharmaceutical Co LtdTakeda Development Center Americas Inc
Inactive CompaniesN/A
Active IndicationsSleepinessNarcolepsyIdiopathic Hypersomnia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A